✦ LIBER ✦

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

✍ Scribed by Popat, U; Hosing, C; Saliba, R M; Anderlini, P; Besien, K van; Przepiorka, D; Khouri, I F; Gajewski, J; Claxton, D; Giralt, S

Book ID: 110014146
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 167 KB
Volume: 33
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704483

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose therapy and autologous hematop

High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric hodgkin’s disease: analysis of the stanford university results and prognostic indices

✍ Y.C Lieskovsky; M Torres; R Wong; R Agarwal; M Amylon; S Donaldson 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 19 KB

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma

✍ El Weshi, A; Rahal, M; Abdelsalam, M; Al Husseini, H; Maghfoor, I; Akhtar, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 200 KB

Consolidative involved field radiotherap

Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study

✍ Christoph Oehler-Jänne; Christian Taverna; Nadine Stanek; Laura Negretti; Urs M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract The role of involved field radiation therapy (IF‐RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non‐Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IF‐RT. A

High-dose therapy with peripheral blood

High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors

✍ K. Neben; S. Hohaus; H. Goldschmidt; G. Egerer; M. T. Voso; A. D. Ho; R. Haas 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 118 KB

Idiopathic pneumonia syndrome after high

Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer

✍ Wong, R; Rondon, G; Saliba, R M; Shannon, V R; Giralt, S A; Champlin, R E; Ueno, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Effectiveness of high dose chemoradiothe

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease

✍ Craig H. Moskowitz; Tarun Kewalramani; Stephen D. Nimer; Maria Gonzalez; Andrew 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB